Cargando…

Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation function

Multiple sclerosis (MS) is an inflammatory, autoimmune disease of the central nervous system. The cause of MS is still unknown but epidemiological and immunological studies have implicated Epstein-Barr virus (EBV), which infects B cells, as a possible etiological agent involved in disease. Of partic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Rhoda A., Miller, Stephen D., Longnecker, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354779/ https://www.ncbi.nlm.nih.gov/pubmed/22616025 http://dx.doi.org/10.1038/srep00353

Ejemplares similares

Epstein-Barr Virus Latent Membrane Protein 2a (Lmp2a) Employs the Slp-65 Signaling Module
por: Engels, Niklas, et al.
Publicado: (2001)

Epstein–Barr virus latent genes
por: Kang, Myung-Soo, et al.
Publicado: (2015)

Epstein–Barr virus-acquired immunodeficiency in myalgic encephalomyelitis—Is it present in long COVID?
por: Ruiz-Pablos, Manuel, et al.
Publicado: (2023)

Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma
por: Salano, Valerie E., et al.
Publicado: (2021)

Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity
por: Munroe, Melissa E., et al.
Publicado: (2021)

Epstein-Barr Virus Encephalitis Presenting As Acute Disseminated Encephalomyelitis: A Challenging Diagnostic Dilemma
por: Pandey, Neelanjana, et al.
Publicado: (2023)

Structural and Mechanistic Insights into the Tropism of Epstein-Barr Virus
por: Möhl, Britta S., et al.
Publicado: (2016)

Vaccination against Epstein–Barr Latent Membrane Protein 1 Protects against an Epstein–Barr Virus-Associated B Cell Model of Lymphoma
por: Soo Hoo, Wesley I., et al.
Publicado: (2023)

Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome
por: Ruiz-Pablos, Manuel, et al.
Publicado: (2021)

Adult-Onset Acute Disseminated Encephalomyelitis with Epstein-Barr Virus Infection
por: Murasawa, Emika, et al.
Publicado: (2022)

Exposure to the Epstein–Barr Viral Antigen Latent Membrane Protein 1 Induces Myelin-Reactive Antibodies In Vivo
por: Lomakin, Yakov, et al.
Publicado: (2017)

Preventive Treatment with Methylprednisolone Paradoxically Exacerbates Experimental Autoimmune Encephalomyelitis
por: Wüst, Simone, et al.
Publicado: (2012)

Epstein-Barr Virus in Systemic Autoimmune Diseases
por: Draborg, Anette Holck, et al.
Publicado: (2013)

Epstein-Barr Virus and Systemic Autoimmune Diseases
por: Houen, Gunnar, et al.
Publicado: (2021)

Epstein–Barr virus LMP2A imposes sensitivity to apoptosis
por: Swanson-Mungerson, Michelle, et al.
Publicado: (2010)

Epstein-Barr Virus Associated Modulation of Wnt Pathway Is Not Dependent on Latent Membrane Protein-1
por: Webb, Natasha, et al.
Publicado: (2008)

Modulation of the tumor microenvironment by Epstein‐Barr virus latent membrane protein 1 in nasopharyngeal carcinoma
por: Yoshizaki, Tomokazu, et al.
Publicado: (2018)

The Possible Effect of B-Cell Epitopes of Epstein–Barr Virus Early Antigen, Membrane Antigen, Latent Membrane Protein-1, and -2A on Systemic Lupus Erythematosus
por: Tu, Jianxin, et al.
Publicado: (2018)

Acute Epstein-Barr virus infection presenting as Guillain-Barre syndrome
por: Wallace, Lindsey A., et al.
Publicado: (2021)

Interleukin-19 Abrogates Experimental Autoimmune Encephalomyelitis by Attenuating Antigen-Presenting Cell Activation
por: Horiuchi, Hiroshi, et al.
Publicado: (2021)

Epstein–Barr virus nuclear antigen 2 extensively rewires the human chromatin landscape at autoimmune risk loci
por: Hong, Ted, et al.
Publicado: (2021)

Toll-Like Receptor 7 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1
por: Valente, Robert M., et al.
Publicado: (2012)

Latent Membrane Protein 1 Is a Novel Determinant of Epstein-Barr Virus Genome Persistence and Reactivation
por: Caves, Elizabeth A., et al.
Publicado: (2017)

Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma
por: Vrzalikova, Katerina, et al.
Publicado: (2018)

Prognostic Role of the Expression of Latent-Membrane Protein 1 of Epstein–Barr Virus in Classical Hodgkin Lymphoma
por: Santisteban-Espejo, Antonio, et al.
Publicado: (2021)

Potential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus
por: Smith, Danielle Westhoff, et al.
Publicado: (2013)

Human Cd4(+) T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1
por: Münz, Christian, et al.
Publicado: (2000)

Dysregulated follicular regulatory T cells and antibody responses exacerbate experimental autoimmune encephalomyelitis
por: Luo, Lin, et al.
Publicado: (2021)

Epstein-Barr Virus as a Trigger of Autoimmune Liver Diseases
por: Rigopoulou, Eirini I., et al.
Publicado: (2012)

Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus
por: Jog, Neelakshi R., et al.
Publicado: (2021)

Recurrent Plasmodium falciparum Malaria Infections in Kenyan Children Diminish T-Cell Immunity to Epstein Barr Virus Lytic but Not Latent Antigens
por: Snider, Cynthia J., et al.
Publicado: (2012)

Membrane Anchoring of Epstein-Barr Virus gp42 Inhibits Fusion with B Cells Even with Increased Flexibility Allowed by Engineered Spacers
por: Rowe, Cynthia L., et al.
Publicado: (2015)

Epstein-Barr virus infection and variants of Epstein-Barr nuclear antigen-1 in synovial　tissues of rheumatoid arthritis
por: Masuoka, Shotaro, et al.
Publicado: (2018)

Assessment of the prognostic impact of the Epstein–Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease
por: Glavina-Durdov, M, et al.
Publicado: (2001)

Latent Membrane Protein 1 Is Dispensable for Epstein-Barr Virus Replication in Human Embryonic Kidney 293 cells
por: Geiser, Vicki, et al.
Publicado: (2011)

Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein-Barr virus Latent Membrane Protein-1
por: Dellis, Olivier, et al.
Publicado: (2009)

The Effect of Epstein-Barr Virus Latent Membrane Protein 2 Expression on the Kinetics of Early B Cell Infection
por: Wasil, Laura R., et al.
Publicado: (2013)

NF-κB and IRF7 Pathway Activation by Epstein-Barr Virus Latent Membrane Protein 1
por: Ersing, Ina, et al.
Publicado: (2013)

Upregulation of Endocan by Epstein-Barr Virus Latent Membrane Protein 1 and Its Clinical Significance in Nasopharyngeal Carcinoma
por: Yu, Ping-Hung, et al.
Publicado: (2013)

N-acetylcysteine (NAC) ameliorates Epstein-Barr virus latent membrane protein 1 induced chronic inflammation
por: Gao, Xiao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hhsgajhmcklu1hut17sjqd6h7d